Tocagen Inc of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2012-12-05. The offering totals $15.0M, of which $9.1M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Donald Williams | Director | Carlsbad, CA |
| Antony Riley | Executive Officer | Dalla, TX |
| Stephen Doberstein | Director | Dallas, TX |
| Scott Brun | Director | Dallas, TX |
| Lawrence Eichenfield | Director | Dallas, TX |
| Hubert Chen | Executive Officer | Dallas, TX |
| Steven Kornfeld | Director | Dallas, TX |
| David Gryska | Director | Dallas, TX |
| Barbara Fink | Director | Dallas, TX |
| Paul Wagner | Director | Spokane, WA |
| Paul Wagner | Executive Officer | Spokane, WA |
| Dennis Berman | Director | Atlanta, GA |
| Dennis Berman | Executive Officer | Atlanta, GA |
| Franklin M Berger | Director | South San Francisco, CA |
| Thomas Darcy | Director | San Diego, CA |
| Thomas Darcy | Executive Officer | San Diego, CA |
| Faheem M Hasnain | Director | San Diego, CA |
| Harry Gruber | Director | San Diego, CA |
| Harry Gruber | Executive Officer | San Diego, CA |
| Mark J Foletta | Executive Officer | San Diego, CA |
| Douglas Jolly | Executive Officer | San Diego, CA |
| David R Parkinson | Director | San Diego, CA |
| Lori R Kunkel | Director | San Diego, CA |
| Martin J Duvall | Director | San Diego, CA |
| Martin J Duvall | Executive Officer | San Diego, CA |
Showing 15 of 20 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-08-09 | D | $25.0M | $25.0M |
| 2017-03-13 | D/A | $13.0M | $10.9M |
| 2016-12-06 | D | $10.0M | $2.7M |
| 2015-10-22 | D/A | $50.4M | $46.2M |
| 2015-08-10 | D/A | $39.9M | $28.8M |
| 2014-07-03 | D/A | $15.8M | $8.5M |
| 2013-06-10 | D | $5.3M | $210K |
| 2012-03-07 | D | $5.0M | $1.1M |
| 2011-11-08 | D/A | $28.2M | $15.3M |
| 2011-02-16 | D/A | $9.9M | $3.7M |
| 2011-01-04 | D | $3.3M | $1.1M |
| 2010-10-05 | D/A | $12.0M | $5.3M |
| 2010-07-23 | D | $6.0M | $2.1M |
| 2010-03-05 | D | $8.0M | $7.8M |
| 2010-02-26 | D | $3.0M | $3.0M |